Perturbations in human bile acid profiles following drug-induced liver injury investigated using semitargeted high-resolution mass spectrometry
The median age of PMOS diagnosis was 28 in every year of the analysis
Studies in inflammatory bowel disease models show KPV reducing intestinal inflammation markers without the systemic immunosuppressive effects associated with conventional treatments
These materials are supplied to support scientific investigation and are not intended for human consumption or medical use
L-Carnitine-combination group showed a significant increase from baseline in the total mTOR protein levels at week 8, prior to strength testing ( P = 0.017), and this increase was 2-fold greater than that of the placebo group ( P = 0.039) (Fig
da Silva LM, Allemand A, Mendes DAG, dos Santos AC, Andr E, de Souza LM, et al